Illumina share price drops as Roche's takeover attempts hit a wall

Article Date: 13/04/2012 10:00
Illumina share price drops as Roche's takeover attempts hit a wall

Vacancy Search

Quick job search

Advanced Search

Latest News

FDA approves Merck & Co's Ragwitek

FDA approves Merck & Co's Ragwitek

Orphan status for BI leukaemia drug in USA and EU

Orphan status for BI leukaemia drug in USA and EU

OxSyBio raises £1m to develop 3D bio printer

OxSyBio raises £1m to develop 3D bio printer

Upcoming events: US decision time for Pozen and data for Merrimack’s lead asset

Welcome to your weekly digest of approaching regulatory and clinical readouts. The US FDA is due to decide on April 25 on Pozen’s so called “safer aspirins”, PA32540 and PA8140, which have...

BioAlliance moves on Topotarget before key US decision

The all-share move that will see France’s BioAlliance buy Denmark’s Topotarget appears to represent a logical combination of two small, oncology-focused drug developers in search of critical...

NHS England to fund hepatitis C drug Sovaldi

NHS England to fund hepatitis C drug Sovaldi

UK industry/MHRA generics quality forum launches

UK industry/MHRA generics quality forum launches

EMA warns about falsifed Herceptin

EMA warns about falsifed Herceptin

MHRA business plan: new products, services, income streams

MHRA business plan: new products, services, income streams

France's BioAlliance merges with Topotarget of Denmark

France's BioAlliance merges with Topotarget of Denmark
more news